TARGETING
CANCER STEM CELLS

A novel anti-cancer strategy to fight agressive tumor cells in incurable cancers

VIRTU THERAPEUTICS

Virtu Therapeutics is a privately-held pre-clinical-stage pharmaceutical company, founded in 2023, which aims to develop a breakthrough therapeutic solution to combat the most aggressive cancer cells.

The company has a particular focus on Adult and pediatric cancers and primitive brain tumors as glioBlastoma.

Partners

universté côte d'azur
chu de Nice Institut de Biologie Valrose
SATT SUD EST
institut de biologie valrose ibv unice
CNRS Innovation
UCA INNOVATION CENTRE FOR ENTREPRENEURSHIP
Eurobiomed
incubateur PCA
BPI France virtu therapeutics

Foundations and patient associations

Eva pour la vie
EVA pour la vie association de défense des enfants victimes de cancers
université côte d'azur fondation

Awards

foundations patients associations for virtu therapeutics
universté côte d'azur
concours innovation i-LAB
RISE